(Q83791711)

English

Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues

scientific article published on 01 June 2009

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19426125

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19426125%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

review article

1 reference

stated in

Europe PubMed Central

title

Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19426125

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19426125%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

1 reference

Nathaniel A Brown

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19426125

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19426125%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

publication date

1 June 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19426125

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19426125%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

published in

Expert Opinion on Investigational Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19426125

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19426125%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

volume

18

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19426125

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19426125%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19426125

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19426125%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

page(s)

709-725

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19426125

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19426125%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

Identifiers

DOI

10.1517/13543780902854194

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19426125

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19426125%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 January 2020

PubMed publication ID

19426125

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19426125

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19426125%20AND%20SRC:MED&resulttype=core&format=json

(Q83791711)

Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)